SCHEMBL4295164

SCHEMBL4295164

CCCNC(=O)C1CCC1N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.46
CHRNB4 P30926 1/20 0.46
CHRNA3 P32297 1/20 0.46
CHRNA7 P36544 1/20 0.46
CHRNA4 P43681 1/20 0.46
GRM4 Q14833 1/20 0.43
POLB P06746 2/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 2/20 0.41
EPHX1 P07099 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.39
NAAA Q02083 1/20 0.39
EPHX2 P34913 1/20 0.39
BCHE P06276 1/20 0.38
PRCP P42785 1/20 0.38
MAPT P10636 1/20 0.37
ATM Q13315 1/20 0.37
BACE1 P56817 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2521351 0.89 GRM4 (0.48) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL3578694 0.89 GRM4 (0.48) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL11616910 0.79 NAAA (0.53) POLBEPHX1L3MBTL1NAAAPRCP
SCHEMBL11616912 0.79 NAAA (0.53) POLBEPHX1L3MBTL1NAAAPRCP
SCHEMBL5350167 0.77 CHRNB2 (0.46) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL23637868 0.76 CHRNB2 (0.49) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL24515735 0.76 SMN1; SMN2 (0.42) POLBHSD17B10
SCHEMBL7677400 0.74 POLB (0.51) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL2226371 0.73 NAAA (0.50) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL14393082 0.73 POLB (0.80) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8623887-B2 Compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-01-07 US disclosed
US-20090163467-A1 New compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163467-A1 New compounds CCNA1, MKI67, CCNT1 CHRNB2 2548/4885CHRNB4 2779/4885CHRNA3 3307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.